| Validating the EQ-5D with time trade off for the German population W Greiner, C Claes, JJV Busschbach, JM Graf von der Schulenburg The European journal of health economics 6, 124-130, 2005 | 457 | 2005 |
| German value set for the EQ-5D-5L K Ludwig, JM Graf von der Schulenburg, W Greiner Pharmacoeconomics 36, 663-674, 2018 | 317 | 2018 |
| Adult diapause in Coleoptera I Hodek Psyche: A Journal of Entomology 2012, 1-10, 2012 | 245 | 2012 |
| The influence of economic evaluation studies on decision making.: A European survey C Hoffmann, JMG von der Schulenburg Health policy 52 (3), 179-192, 2000 | 237 | 2000 |
| Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting K Schmidt, I Aumann, I Hollander, K Damm, JMG von der Schulenburg BMC medical informatics and decision making 15, 1-27, 2015 | 208 | 2015 |
| Die deutsche Version des EuroQol-Fragebogens. JM Graf, C Claes, W Greiner, A Uber Journal of Public Health (09431853) 6 (1), 1998 | 204 | 1998 |
| German recommendations on health economic evaluation: third and updated version of the Hanover Consensus JM Graf von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, ... Value in health 11 (4), 539-544, 2008 | 158 | 2008 |
| Consumer information and decisions to switch insurers H Schlesinger, JMG von der Schulenburg Journal of Risk and Insurance, 591-615, 1993 | 153 | 1993 |
| Gesundheitsökonomik J Schulenburg Mohr Siebeck, 2013 | 149 | 2013 |
| Search costs, switching costs and product heterogeneity in an insurance market H Schlesinger, JMG Von der Schulenburg Journal of Risk and Insurance, 109-119, 1991 | 146 | 1991 |
| Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation-dritte und aktualisierte Fassung des Hannoveraner Konsens JMG von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, R Leidl, ... Gesundheitsökonomie & Qualitätsmanagement 12 (05), 285-290, 2007 | 137 | 2007 |
| Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources J Ruof, JL Hülsemann, T Mittendorf, S Handelmann, ... Annals of the rheumatic diseases 62 (6), 544-549, 2003 | 127 | 2003 |
| Cost of poor adherence to anti-hypertensive therapy in five European countries FS Mennini, A Marcellusi, JMG von Der Schulenburg, A Gray, P Lévy, ... The European journal of health economics 16, 65-72, 2015 | 119 | 2015 |
| Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare B Jönsson, G Hampson, J Michaels, A Towse, JMG von der Schulenburg, ... The European journal of health economics 20, 427-438, 2019 | 117 | 2019 |
| Cost of care and clinical condition in paediatric cystic fibrosis patients U Baumann, C Stocklossa, W Greiner, JMG von der Schulenburg, ... Journal of Cystic Fibrosis 2 (2), 84-90, 2003 | 108 | 2003 |
| Risikoethik J Nida-Rümelin, J Schulenburg, B Rath Walter de Gruyter, 2012 | 92 | 2012 |
| Stereotactic radiosurgery for the treatment of brain metastases F Müller-Riemenschneider, A Bockelbrink, I Ernst, C Schwarzbach, ... Radiotherapy and Oncology 91 (1), 67-74, 2009 | 89 | 2009 |
| A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer A Lange, A Prenzler, M Frank, M Kirstein, A Vogel, ... European journal of cancer 50 (1), 40-49, 2014 | 81 | 2014 |
| Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe A Angelis, P Kanavos, J López-Bastida, R Linertová, J Oliva-Moreno, ... The European Journal of Health Economics 17, 31-42, 2016 | 80 | 2016 |
| Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ... The European Journal of Health Economics 17, 19-29, 2016 | 80 | 2016 |
